Skip to main content
Medicover logo

Medicover — Investor Relations & Filings

Ticker · MCOV ISIN · SE0009778848 LEI · 5493000E9BUOYMOW2K53 ST Human health and social work activities
Open in API
Filings indexed 285 across all filing types
Latest filing 2021-01-29 Board/Management Inform…
Country SE Sweden
Listing ST MCOV

About Medicover

https://www.medicover.com/

Medicover is an international healthcare and diagnostic services provider. The company operates through two main divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division delivers a broad range of medical care, including primary care, specialist consultations, and hospital treatment. The Diagnostic Services division offers a comprehensive array of laboratory tests, from routine to advanced diagnostics, serving a wide network of clients. Committed to patient-centric care, Medicover focuses on quality, accessibility, and affordability by investing in modern medical technology and innovation. Its core mission is to improve and sustain the health and wellbeing of its customers.

Recent filings

Filing Released Lang Actions
Diagnostic Services COO Benedikt von Braunmühl has decided to leave the company
Board/Management Information Classification · 1% confidence The document is a short press release dated January 29, 2021, announcing that the COO of Diagnostic Services, Benedikt von Braunmühl, has decided to leave the company. This content directly relates to a change in senior management personnel. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category.
2021-01-29 English
Number of shares and votes in Medicover
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short press release dated November 30, 2020, announcing a change in the total number of shares and votes due to share class conversions (A to B shares). This directly relates to changes in the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes in capital structure, including share counts resulting from conversions. It is not a general earnings release (ER), a dividend notice (DIV), or a director's dealing report (DIRS). Given the specific nature of the announcement regarding share counts and voting rights changes due to internal mechanisms, SHA is the most precise fit over the general 'RNS' fallback.
2020-11-30 English
Antal aktier och röster i Medicover
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a 'Pressmeddelande' (Press Release) dated November 30, 2020, titled 'ANTAL AKTIER OCH RÖSTER I MEDICOVER' (Number of Shares and Votes in Medicover). It details a change in the total number of shares and votes due to the conversion of A-shares to B-shares. This type of announcement, which reports on changes in the capital structure (specifically the total voting rights/share count), aligns best with the 'Share Issue/Capital Change' category (SHA). Although it is a regulatory disclosure ('Medicover är skyldigt att offentliggöra informationen...'), SHA is more specific than the general RNS fallback. The document length is short (1530 chars), but it contains the substantive information rather than just announcing another report.
2020-11-30 Swedish
Earnings Release 2020
Earnings Release Classification · 1% confidence The document is titled "DELÅRSRAPPORT JULI–SEPTEMBER 2020" (Interim Report July–September 2020) and provides detailed financial figures for the third quarter (Kv 3 2020) and the first nine months (9M 2020) of the fiscal year, including Net Sales, EBIT, Net Income, EBITDA, and EPS. The content is comprehensive, covering operational performance, segment breakdowns (Healthcare Services and Diagnostic Services), management commentary (VD-ORD), and outlook. This structure and content strongly indicate a formal, comprehensive financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). It is not an Earnings Release (ER) because it is too detailed and comprehensive, nor is it an Annual Report (10-K) as it covers only nine months. Q3 2020
2020-11-06 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT JULY–SEPTEMBER 2020' and contains comprehensive financial statements, including revenue, operating profit, net profit, EBITDA, and cash flow data for the third quarter and nine-month period. It includes detailed management analysis, CEO statements, and segment-specific performance breakdowns. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2020
2020-11-06 English
Trading update Q3 – Robust recovery
Earnings Release Classification · 1% confidence The document is explicitly titled a "TRADING UPDATE Q3" and states that Medicover AB is "issuing a trading update before it releases its interim report as planned on the 6th November 2020." It provides preliminary, unaudited key financial highlights (revenue, EBITDA, EBIT) for the quarter ended September 30, 2020. This content structure—a preliminary release of key figures ahead of the full quarterly report—is characteristic of an Earnings Release (ER). It is not the full Interim Report (IR) itself, nor is it a general regulatory announcement (RNS) since it fits the specific 'ER' definition better. The document length (4757 chars) is substantial enough to be more than just a brief announcement of a report being attached (RPA). Q3 2020
2020-10-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.